PA-BOOMI
9.4.2024 15:01:34 CEST | Business Wire | Press release
Boomi™, the intelligent integration and automation leader, is thrilled to announce Boomi World is back. The company’s highly anticipated industry event will take place May 6-9, 2024 at the Sheraton Denver Downtown Hotel in Denver, Colorado. Boomi World 2024 promises to be a transformative experience, bringing together industry leaders, technology experts, and visionary professionals to explore the latest trends and innovations in AI, integration, and automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240409873041/en/
Boomi World 2024 User Conference to Feature Deion “Coach Prime” Sanders (Graphic: Business Wire)
Emceed by technology industry veteran and correspondent Lisa Martin, Boomi World 2024 will feature esteemed guest speakers, including:
- Collegiate Head Football Coach and Pro Football Hall of Famer Deion Sanders
- Tropicana CIO Jeff Lischett
- Australian Red Cross CIO Brett Wilson
- Fever-Tree Head of Technology Kate Stables
- KORE Wireless Senior Director of Enterprise Applications Nicki Brock
- OSI Digital CMO Karen Dosanjh
- Gartner Senior Director Analyst John Santoro
- BARC US CEO Shawn Rogers
- IDC Research Director/Analyst Shari Lava
- Boomi CEO Steve Lucas
- Boomi Chief Product and Technology Officer Ed Macosky
- Boomi CTO Matt McLarty; and more!
Boomi World 2024 will provide attendees the opportunity to experience the power of AI-driven connection. Boomi’s customers and partners will discover how Boomi’s intelligent integration and automation platform helps organizations tame IT complexity, drive radical innovation, and synchronize everything, everywhere.
Event Highlights:
1. Robust Agenda
Boomi World 2024 boasts a dynamic and comprehensive agenda, featuring thought-provoking sessions, hands-on workshops, and engaging panel discussions. Attendees will have the opportunity to dive into the latest advancements in integration technology, best practices, and success stories from forward-thinking enterprises across industries that have transformed their organizations with Boomi.
2. Special Guest Deion Sanders
Boomi welcomes Deion Sanders, aka “Coach Prime,” as its special guest speaker.
As head coach from 2020-2022, Sanders led Jackson State University (JSU) to back-to-back SWAC Championships, and won back-to-back SWAC Coach of the Year honors. During his time at JSU, the Tigers had a 27-6 record, including a perfect regular season in 2022. In 2021, he was named the Eddie Robinson Coach of the Year.
Sanders is a member of the Pro Football Hall of Fame, a two-time Super Bowl champion, and eight-time Pro Bowler. He played 14 years in the NFL for the Atlanta Falcons, San Francisco 49ers, Dallas Cowboys, Washington Commanders, and Baltimore Ravens. Sanders is the only person in professional sports history to play in both the World Series and the Super Bowl.
After retiring from professional sports, Sanders became an analyst for CBS Sports and NFL Network, and now offers his insights and opinions on the Pro Football Show on Barstool Sports. He has produced and/or appeared in a variety of television shows, including Tiny House Nation, Grandfathered, Moesha, Running Wild With Bear Grylls, Lip Sync Battle, The League, 30 For 30: Deion’s Double Play, Deion’s Family Playbook, and, most recently, Coach Prime, a docuseries on Prime Video which follows Sanders and his college football journey.
3. Exclusive Announcements
Be the first to hear Boomi's latest product and platform updates, roadmap, and strategic initiatives. Boomi World 2024 will feature exclusive announcements that will shape the future of AI, integration, and automation.
4. Pre-Conference Training and Partner Summit
Starting on May 6, Boomi World will provide optional one and two-day Pre-Conference Training and certification courses, with in-depth sessions covering the various Platform Services within the Boomi platform, including Integration, runtime architecture, API Management, and Master Data Hub.
Taking place on May 7, the Boomi Partner Summit provides partners an exclusive look at the future of the Boomi ecosystem. Partners will get a sneak peek at upcoming announcements and gain access to go-to-market resources designed to drive growth while helping customers more quickly and easily connect, automate, and modernize their digital landscape.
5. 40+ Breakout Sessions
Boomi World will offer more than 40 breakout sessions focused on the following four tracks:
Hands-On Labs will offer attendees the opportunity to explore what’s new in the Boomi platform, get creative with AI, and learn about Retrieval-Augmented Generation — including how to set up a RAG using Boomi.
Developer/Technical track, which will include sessions on popular integration use cases, runtime monitoring, error-handling strategies, master data management, and “Boomi on Boomi” solutions.
CIO/Executive track for executive attendees — or anyone interested in topics designed to appeal to CIOs — which will feature sessions on risk management, Boomi platform security, and AI readiness.
Innovation track, which will include a wide range of sessions from customers, partners, industry analysts, and Boomi technology experts designed to showcase the myriad ways the Boomi platform can be used to connect and transform organizations.
6. Networking Opportunities
Connect with like-minded professionals, industry experts, and Boomi partners during dedicated networking sessions. Boomi World 2024 provides a unique platform to foster collaboration, share ideas, and build valuable relationships within the integration, automation, and connectivity community.
Sponsors:
A special thanks to Boomi’s partner sponsors for helping make Boomi World 2024 possible, including Cognizant and Infosys as Diamond sponsors, and Apica, Kitepipe, LTIMindtree, R Systems, TCS, and United Techno as Platinum sponsors.
Registration:
Registration is now open. Secure your spot at Boomi World 2024 by visiting BoomiWorld.com.
To join the Boomi World conversation on social media, use #BoomiWorld.
Additional Resources
- Learn more about the Boomi platform
- Follow Boomi on LinkedIn, X (Twitter), Facebook, and YouTube
About Boomi
Boomi powers the future of business with intelligent integration and automation. As a category-leading, global software as a service (SaaS) company, Boomi celebrates more than 20,000 global customers and a worldwide network of 800 partners. Organizations turn to Boomi’s award-winning platform to connect their applications, data, and people to accelerate digital transformation. For more information, visit boomi.com.
© 2024 Boomi, LP. Boomi, the ‘B’ logo, and Boomiverse are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240409873041/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom